Groundbreaking studies reveal novel molecular mechanisms and metabolic vulnerabilities in cancer. Discoveries include new enzyme families degrading bacterial carbohydrates, emerging tumor energy pathways disrupted by natural compounds, and specific modulators restricting breast cancer progression. Additionally, dual-laser photothermal therapy enhances breast cancer ablation efficiency while minimizing tissue damage. These insights sharpen targeted therapy development and underscore metabolic reprogramming as a critical area in oncology.